Structure

Physi-Chem Properties

Molecular Weight:  494.22
Volume:  475.53
LogP:  1.528
LogD:  0.852
LogS:  -4.049
# Rotatable Bonds:  4
TPSA:  156.66
# H-Bond Aceptor:  10
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.364
Synthetic Accessibility Score:  6.743
Fsp3:  0.84
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.383
MDCK Permeability:  7.320521399378777e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.347
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.052
30% Bioavailability (F30%):  0.946

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.51
Plasma Protein Binding (PPB):  39.00489807128906%
Volume Distribution (VD):  0.508
Pgp-substrate:  46.816104888916016%

ADMET: Metabolism

CYP1A2-inhibitor:  0.008
CYP1A2-substrate:  0.967
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.495
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.018
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.075
CYP3A4-inhibitor:  0.375
CYP3A4-substrate:  0.253

ADMET: Excretion

Clearance (CL):  2.722
Half-life (T1/2):  0.167

ADMET: Toxicity

hERG Blockers:  0.031
Human Hepatotoxicity (H-HT):  0.372
Drug-inuced Liver Injury (DILI):  0.756
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.308
Maximum Recommended Daily Dose:  0.093
Skin Sensitization:  0.183
Carcinogencity:  0.097
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.67

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC235539

Natural Product ID:  NPC235539
Common Name*:   Glaucarubinone
IUPAC Name:   n.a.
Synonyms:   NSC-14975
Standard InCHIKey:  WRBGCYVAJRRQKP-STDAJNJZSA-N
Standard InCHI:  InChI=1S/C25H34O10/c1-6-22(4,31)21(30)35-16-15-11(3)17(27)25(32)20-23(5)12(10(2)7-13(26)18(23)28)8-14(34-19(16)29)24(15,20)9-33-25/h7,11-12,14-18,20,27-28,31-32H,6,8-9H2,1-5H3/t11-,12+,14-,15-,16-,17-,18-,20-,22+,23-,24+,25+/m1/s1
SMILES:  CC[C@@](C(=O)O[C@H]1C(=O)O[C@H]2[C@]34[C@@H]1[C@@H](C)[C@@H](O)[C@@]([C@@H]4[C@@]1([C@@H](C2)C(=CC(=O)[C@H]1O)C)C)(OC3)O)(O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458347
PubChem CID:   441796
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0002119] Quassinoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32507 odyendyea gabonensis Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[20738103]
NPO4432 0thospondias staudtii Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[21733691]
NPO6324 Soulamea tomentosa Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[7264678]
NPO30695 Allanthus excelsa n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]
NPO4432 0thospondias staudtii Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 500.0 nM PMID[512757]
NPT116 Cell Line HL-60 Homo sapiens EC50 = 1800.0 nM PMID[512757]
NPT116 Cell Line HL-60 Homo sapiens IC50 = 1000.0 nM PMID[512757]
NPT116 Cell Line HL-60 Homo sapiens Ratio IC50 = 2.1 n.a. PMID[512757]
NPT168 Cell Line P388 Mus musculus T/C = 231.0 % PMID[512758]
NPT165 Cell Line HeLa Homo sapiens IC50 = 270.0 nM PMID[512760]
NPT90 Cell Line DU-145 Homo sapiens ED50 = 0.47 uM PMID[512762]
NPT81 Cell Line A549 Homo sapiens ED50 = 0.88 uM PMID[512762]
NPT91 Cell Line KB Homo sapiens ED50 = 0.44 uM PMID[512762]
NPT367 Cell Line MDA-N Homo sapiens GI50 n.a. 424.62 nM PMID[512764]
NPT368 Cell Line SN12C Homo sapiens GI50 n.a. 157.76 nM PMID[512764]
NPT369 Cell Line ACHN Homo sapiens GI50 n.a. 292.42 nM PMID[512764]
NPT370 Cell Line NCI-H23 Homo sapiens GI50 n.a. 79.62 nM PMID[512764]
NPT371 Cell Line UO-31 Homo sapiens GI50 n.a. 377.57 nM PMID[512764]
NPT372 Cell Line HOP-92 Homo sapiens GI50 n.a. 48.98 nM PMID[512764]
NPT116 Cell Line HL-60 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT90 Cell Line DU-145 Homo sapiens GI50 n.a. 824.14 nM PMID[512764]
NPT373 Cell Line SK-MEL-5 Homo sapiens GI50 n.a. 44.16 nM PMID[512764]
NPT374 Cell Line SF-539 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT375 Cell Line Malme-3M Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT111 Cell Line K562 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT376 Cell Line A498 Homo sapiens GI50 n.a. 319.89 nM PMID[512764]
NPT377 Cell Line OVCAR-3 Homo sapiens GI50 n.a. 98.17 nM PMID[512764]
NPT112 Cell Line MOLT-4 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT379 Cell Line HOP-62 Homo sapiens GI50 n.a. 79.43 nM PMID[512764]
NPT378 Cell Line NCI/ADR-RES Homo sapiens GI50 n.a. 2269.86 nM PMID[512764]
NPT380 Cell Line U-251 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT381 Cell Line OVCAR-8 Homo sapiens GI50 n.a. 75.34 nM PMID[512764]
NPT382 Cell Line OVCAR-5 Homo sapiens GI50 n.a. 657.66 nM PMID[512764]
NPT572 Cell Line DMS-273 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 n.a. 946.24 nM PMID[512764]
NPT383 Cell Line SNB-19 Homo sapiens GI50 n.a. 93.33 nM PMID[512764]
NPT385 Cell Line SR Homo sapiens GI50 n.a. 45.29 nM PMID[512764]
NPT384 Cell Line TK-10 Homo sapiens GI50 n.a. 389.94 nM PMID[512764]
NPT573 Cell Line M19-MEL Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT323 Cell Line SW-620 Homo sapiens GI50 n.a. 74.99 nM PMID[512764]
NPT386 Cell Line KM12 Homo sapiens GI50 n.a. 60.39 nM PMID[512764]
NPT455 Cell Line NCI-H522 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT387 Cell Line M14 Homo sapiens GI50 n.a. 106.91 nM PMID[512764]
NPT388 Cell Line NCI-H322M Homo sapiens GI50 n.a. 2123.24 nM PMID[512764]
NPT574 Cell Line XF498 Homo sapiens GI50 n.a. 54.2 nM PMID[512764]
NPT389 Cell Line RPMI-8226 Homo sapiens GI50 n.a. 54.83 nM PMID[512764]
NPT456 Cell Line OVCAR-4 Homo sapiens GI50 n.a. 320.63 nM PMID[512764]
NPT390 Cell Line LOX IMVI Homo sapiens GI50 n.a. 35.4 nM PMID[512764]
NPT168 Cell Line P388 Mus musculus GI50 n.a. 67.61 nM PMID[512764]
NPT457 Cell Line BT-549 Homo sapiens GI50 n.a. 229.09 nM PMID[512764]
NPT147 Cell Line SK-MEL-2 Homo sapiens GI50 n.a. 62.52 nM PMID[512764]
NPT575 Cell Line KM-20L2 Homo sapiens GI50 n.a. 171.0 nM PMID[512764]
NPT391 Cell Line HCC 2998 Homo sapiens GI50 n.a. 67.92 nM PMID[512764]
NPT81 Cell Line A549 Homo sapiens GI50 n.a. 1213.39 nM PMID[512764]
NPT392 Cell Line SNB-75 Homo sapiens GI50 n.a. 58.48 nM PMID[512764]
NPT148 Cell Line HCT-15 Homo sapiens GI50 n.a. 88.51 nM PMID[512764]
NPT393 Cell Line HCT-116 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT395 Cell Line SF-268 Homo sapiens GI50 n.a. 66.07 nM PMID[512764]
NPT394 Cell Line EKVX Homo sapiens GI50 n.a. 54.45 nM PMID[512764]
NPT306 Cell Line PC-3 Homo sapiens GI50 n.a. 458.14 nM PMID[512764]
NPT83 Cell Line MCF7 Homo sapiens GI50 n.a. 198.61 nM PMID[512764]
NPT146 Cell Line SK-OV-3 Homo sapiens GI50 n.a. 1016.25 nM PMID[512764]
NPT731 Cell Line LXFL 529 Homo sapiens GI50 n.a. 11.09 nM PMID[512764]
NPT576 Cell Line DMS-114 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT396 Cell Line T47D Homo sapiens GI50 n.a. 176.2 nM PMID[512764]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 n.a. 91.2 nM PMID[512764]
NPT398 Cell Line UACC-62 Homo sapiens GI50 n.a. 51.05 nM PMID[512764]
NPT308 Cell Line CAKI-1 Homo sapiens GI50 n.a. 207.01 nM PMID[512764]
NPT399 Cell Line SF-295 Homo sapiens GI50 n.a. 115.61 nM PMID[512764]
NPT400 Cell Line MDA-MB-435 Homo sapiens GI50 n.a. 1396.37 nM PMID[512764]
NPT552 Cell Line P388/ADR Mus musculus GI50 n.a. 663.74 nM PMID[512764]
NPT458 Cell Line IGROV-1 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT402 Cell Line Hs-578T Homo sapiens GI50 n.a. 167.11 nM PMID[512764]
NPT401 Cell Line 786-0 Homo sapiens GI50 n.a. 145.88 nM PMID[512764]
NPT577 Cell Line RXF 631 Homo sapiens GI50 n.a. 543.25 nM PMID[512764]
NPT403 Cell Line UACC-257 Homo sapiens GI50 n.a. 67.45 nM PMID[512764]
NPT578 Cell Line SNB-78 Homo sapiens GI50 n.a. 66.83 nM PMID[512764]
NPT579 Cell Line DLD-1 Homo sapiens GI50 n.a. 50.47 nM PMID[512764]
NPT404 Cell Line CCRF-CEM Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT139 Cell Line HT-29 Homo sapiens GI50 n.a. 238.78 nM PMID[512764]
NPT405 Cell Line NCI-H226 Homo sapiens GI50 n.a. 113.24 nM PMID[512764]
NPT170 Cell Line SK-MEL-28 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT406 Cell Line RXF 393 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT407 Cell Line COLO 205 Homo sapiens GI50 n.a. 814.7 nM PMID[512764]
NPT732 Cell Line HOP-18 Homo sapiens GI50 n.a. 252.93 nM PMID[512764]
NPT738 Cell Line SN12K1 Homo sapiens GI50 n.a. 50.0 nM PMID[512764]
NPT27 Others Unspecified Selectivity ratio = 285.0 n.a. PMID[512759]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 1800.0 nM PMID[512760]
NPT2 Others Unspecified INH = 0.29 uM PMID[512760]
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens IC50 = 40.0 nM PMID[512760]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 21000.0 nM PMID[512761]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition < 25.0 % PMID[512760]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 1.24 uM PMID[512762]
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens EC50 = 130.0 nM PMID[512763]
NPT992 Organism Entamoeba histolytica Entamoeba histolytica IC50 = 0.168 ug.mL-1 PMID[512765]
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens EC50 = 1490.0 nM PMID[512766]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC235539 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC134869
1.0 High Similarity NPC152199
0.9906 High Similarity NPC18547
0.9906 High Similarity NPC474906
0.9815 High Similarity NPC297179
0.9717 High Similarity NPC11252
0.9717 High Similarity NPC289312
0.963 High Similarity NPC40632
0.963 High Similarity NPC251236
0.963 High Similarity NPC328374
0.963 High Similarity NPC96312
0.9623 High Similarity NPC201992
0.9537 High Similarity NPC473798
0.9459 High Similarity NPC107338
0.9459 High Similarity NPC109607
0.9455 High Similarity NPC204552
0.9455 High Similarity NPC188667
0.945 High Similarity NPC474046
0.945 High Similarity NPC470628
0.945 High Similarity NPC259306
0.9444 High Similarity NPC49451
0.9444 High Similarity NPC51978
0.9369 High Similarity NPC476529
0.9369 High Similarity NPC475775
0.9358 High Similarity NPC470919
0.9358 High Similarity NPC469877
0.934 High Similarity NPC293850
0.9298 High Similarity NPC470922
0.9286 High Similarity NPC112038
0.9279 High Similarity NPC17772
0.9204 High Similarity NPC102822
0.9204 High Similarity NPC477046
0.9196 High Similarity NPC469488
0.9189 High Similarity NPC309433
0.9189 High Similarity NPC470854
0.9189 High Similarity NPC474654
0.9189 High Similarity NPC287343
0.9189 High Similarity NPC97908
0.9189 High Similarity NPC122033
0.9174 High Similarity NPC302146
0.9174 High Similarity NPC474516
0.9099 High Similarity NPC474734
0.9091 High Similarity NPC7921
0.9091 High Similarity NPC208998
0.9065 High Similarity NPC3316
0.9065 High Similarity NPC144854
0.9027 High Similarity NPC470777
0.9018 High Similarity NPC473968
0.9018 High Similarity NPC473590
0.8981 High Similarity NPC154608
0.8981 High Similarity NPC192813
0.8981 High Similarity NPC277017
0.8929 High Similarity NPC16081
0.8929 High Similarity NPC173686
0.8909 High Similarity NPC171888
0.8909 High Similarity NPC146945
0.8899 High Similarity NPC472534
0.8899 High Similarity NPC143706
0.8879 High Similarity NPC227397
0.8879 High Similarity NPC265557
0.8879 High Similarity NPC91693
0.8879 High Similarity NPC18945
0.8879 High Similarity NPC67251
0.8879 High Similarity NPC105926
0.8839 High Similarity NPC45218
0.8839 High Similarity NPC323821
0.8839 High Similarity NPC268238
0.8839 High Similarity NPC143268
0.8803 High Similarity NPC24651
0.8803 High Similarity NPC476729
0.8796 High Similarity NPC102352
0.8793 High Similarity NPC312833
0.8772 High Similarity NPC251310
0.8772 High Similarity NPC470776
0.8761 High Similarity NPC207217
0.875 High Similarity NPC255017
0.875 High Similarity NPC194100
0.8739 High Similarity NPC188291
0.8729 High Similarity NPC285091
0.8727 High Similarity NPC27814
0.8707 High Similarity NPC275675
0.8707 High Similarity NPC470779
0.8696 High Similarity NPC473920
0.8696 High Similarity NPC127530
0.8684 High Similarity NPC470775
0.8684 High Similarity NPC176513
0.8679 High Similarity NPC472972
0.8678 High Similarity NPC100390
0.8678 High Similarity NPC254614
0.8673 High Similarity NPC102088
0.8673 High Similarity NPC243354
0.8661 High Similarity NPC90769
0.8649 High Similarity NPC474567
0.8649 High Similarity NPC210005
0.8632 High Similarity NPC471965
0.8624 High Similarity NPC181357
0.8621 High Similarity NPC471406
0.8584 High Similarity NPC194273
0.8584 High Similarity NPC293038
0.8584 High Similarity NPC62696
0.8583 High Similarity NPC295220
0.8583 High Similarity NPC475636
0.8571 High Similarity NPC471243
0.8571 High Similarity NPC87662
0.8559 High Similarity NPC262199
0.8559 High Similarity NPC141350
0.8559 High Similarity NPC202666
0.8559 High Similarity NPC471964
0.8559 High Similarity NPC478066
0.8559 High Similarity NPC14617
0.8559 High Similarity NPC471961
0.8547 High Similarity NPC75417
0.8545 High Similarity NPC293512
0.8534 High Similarity NPC122971
0.8534 High Similarity NPC319570
0.8534 High Similarity NPC473401
0.8534 High Similarity NPC279143
0.8532 High Similarity NPC475036
0.8532 High Similarity NPC65523
0.8525 High Similarity NPC471855
0.8525 High Similarity NPC102316
0.8512 High Similarity NPC54614
0.8512 High Similarity NPC309096
0.8509 High Similarity NPC475633
0.85 High Similarity NPC470780
0.8496 Intermediate Similarity NPC472002
0.8496 Intermediate Similarity NPC130427
0.8496 Intermediate Similarity NPC471967
0.8496 Intermediate Similarity NPC280782
0.8487 Intermediate Similarity NPC247315
0.8487 Intermediate Similarity NPC471962
0.8487 Intermediate Similarity NPC177820
0.8487 Intermediate Similarity NPC473255
0.8487 Intermediate Similarity NPC471963
0.8487 Intermediate Similarity NPC30188
0.8487 Intermediate Similarity NPC470477
0.848 Intermediate Similarity NPC596
0.8475 Intermediate Similarity NPC249848
0.8475 Intermediate Similarity NPC222688
0.8475 Intermediate Similarity NPC40775
0.8475 Intermediate Similarity NPC235438
0.8475 Intermediate Similarity NPC107966
0.8468 Intermediate Similarity NPC258323
0.8468 Intermediate Similarity NPC262813
0.8468 Intermediate Similarity NPC94942
0.8468 Intermediate Similarity NPC473288
0.8468 Intermediate Similarity NPC272576
0.8455 Intermediate Similarity NPC478151
0.8448 Intermediate Similarity NPC286347
0.8443 Intermediate Similarity NPC134914
0.8443 Intermediate Similarity NPC172374
0.8443 Intermediate Similarity NPC264566
0.8443 Intermediate Similarity NPC478064
0.8443 Intermediate Similarity NPC478065
0.8443 Intermediate Similarity NPC173435
0.8443 Intermediate Similarity NPC301639
0.8443 Intermediate Similarity NPC475167
0.8443 Intermediate Similarity NPC475377
0.8443 Intermediate Similarity NPC476074
0.8443 Intermediate Similarity NPC329993
0.8443 Intermediate Similarity NPC45346
0.8443 Intermediate Similarity NPC262796
0.844 Intermediate Similarity NPC275583
0.844 Intermediate Similarity NPC474575
0.8435 Intermediate Similarity NPC179626
0.8421 Intermediate Similarity NPC320118
0.8421 Intermediate Similarity NPC198539
0.8421 Intermediate Similarity NPC271138
0.8421 Intermediate Similarity NPC269315
0.8421 Intermediate Similarity NPC178981
0.8417 Intermediate Similarity NPC181066
0.8417 Intermediate Similarity NPC174367
0.8417 Intermediate Similarity NPC225049
0.8417 Intermediate Similarity NPC469947
0.8417 Intermediate Similarity NPC47113
0.8407 Intermediate Similarity NPC263827
0.8407 Intermediate Similarity NPC285410
0.8407 Intermediate Similarity NPC250481
0.8403 Intermediate Similarity NPC281148
0.8403 Intermediate Similarity NPC30735
0.8403 Intermediate Similarity NPC235405
0.84 Intermediate Similarity NPC141215
0.84 Intermediate Similarity NPC190065
0.84 Intermediate Similarity NPC251998
0.84 Intermediate Similarity NPC471089
0.8393 Intermediate Similarity NPC218853
0.8393 Intermediate Similarity NPC41405
0.8393 Intermediate Similarity NPC474242
0.8393 Intermediate Similarity NPC310546
0.839 Intermediate Similarity NPC202051
0.8378 Intermediate Similarity NPC230541
0.8376 Intermediate Similarity NPC35405
0.8376 Intermediate Similarity NPC39211
0.8376 Intermediate Similarity NPC469945
0.8376 Intermediate Similarity NPC11551
0.8376 Intermediate Similarity NPC208381
0.8376 Intermediate Similarity NPC473884
0.8376 Intermediate Similarity NPC6377
0.8376 Intermediate Similarity NPC192791
0.8376 Intermediate Similarity NPC157868

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC235539 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8559 High Similarity NPD8328 Phase 3
0.8333 Intermediate Similarity NPD6882 Approved
0.8333 Intermediate Similarity NPD8297 Approved
0.8333 Intermediate Similarity NPD7492 Approved
0.8305 Intermediate Similarity NPD6054 Approved
0.8305 Intermediate Similarity NPD6319 Approved
0.8305 Intermediate Similarity NPD6059 Approved
0.8288 Intermediate Similarity NPD6675 Approved
0.8288 Intermediate Similarity NPD7128 Approved
0.8288 Intermediate Similarity NPD6402 Approved
0.8288 Intermediate Similarity NPD5739 Approved
0.8279 Intermediate Similarity NPD7736 Approved
0.8264 Intermediate Similarity NPD6616 Approved
0.823 Intermediate Similarity NPD6373 Approved
0.823 Intermediate Similarity NPD6372 Approved
0.8205 Intermediate Similarity NPD6009 Approved
0.8205 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.8197 Intermediate Similarity NPD7078 Approved
0.8197 Intermediate Similarity NPD8293 Discontinued
0.8167 Intermediate Similarity NPD6370 Approved
0.8142 Intermediate Similarity NPD6881 Approved
0.8142 Intermediate Similarity NPD7320 Approved
0.8142 Intermediate Similarity NPD6899 Approved
0.8103 Intermediate Similarity NPD4632 Approved
0.8087 Intermediate Similarity NPD6649 Approved
0.8087 Intermediate Similarity NPD6650 Approved
0.8083 Intermediate Similarity NPD6016 Approved
0.8083 Intermediate Similarity NPD6015 Approved
0.807 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.8053 Intermediate Similarity NPD6412 Phase 2
0.8053 Intermediate Similarity NPD5697 Approved
0.8053 Intermediate Similarity NPD5701 Approved
0.8017 Intermediate Similarity NPD5988 Approved
0.8 Intermediate Similarity NPD7102 Approved
0.8 Intermediate Similarity NPD7290 Approved
0.8 Intermediate Similarity NPD6883 Approved
0.7967 Intermediate Similarity NPD7507 Approved
0.7931 Intermediate Similarity NPD6617 Approved
0.7931 Intermediate Similarity NPD6847 Approved
0.7931 Intermediate Similarity NPD6869 Approved
0.7931 Intermediate Similarity NPD8130 Phase 1
0.7913 Intermediate Similarity NPD6014 Approved
0.7913 Intermediate Similarity NPD6012 Approved
0.7913 Intermediate Similarity NPD6013 Approved
0.7826 Intermediate Similarity NPD6686 Approved
0.7826 Intermediate Similarity NPD6011 Approved
0.7826 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD7604 Phase 2
0.7787 Intermediate Similarity NPD5983 Phase 2
0.7778 Intermediate Similarity NPD7319 Approved
0.7778 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD6033 Approved
0.768 Intermediate Similarity NPD6336 Discontinued
0.7658 Intermediate Similarity NPD4755 Approved
0.7658 Intermediate Similarity NPD6084 Phase 2
0.7658 Intermediate Similarity NPD6083 Phase 2
0.7652 Intermediate Similarity NPD6008 Approved
0.7607 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD7748 Approved
0.7542 Intermediate Similarity NPD4634 Approved
0.7523 Intermediate Similarity NPD7515 Phase 2
0.7522 Intermediate Similarity NPD5286 Approved
0.7522 Intermediate Similarity NPD4700 Approved
0.7522 Intermediate Similarity NPD4696 Approved
0.7522 Intermediate Similarity NPD5285 Approved
0.7521 Intermediate Similarity NPD6274 Approved
0.75 Intermediate Similarity NPD7902 Approved
0.748 Intermediate Similarity NPD7101 Approved
0.748 Intermediate Similarity NPD7100 Approved
0.748 Intermediate Similarity NPD7516 Approved
0.7459 Intermediate Similarity NPD7115 Discovery
0.7398 Intermediate Similarity NPD7327 Approved
0.7398 Intermediate Similarity NPD7328 Approved
0.7398 Intermediate Similarity NPD6335 Approved
0.7395 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4633 Approved
0.7391 Intermediate Similarity NPD5224 Approved
0.7391 Intermediate Similarity NPD5226 Approved
0.7391 Intermediate Similarity NPD5225 Approved
0.7391 Intermediate Similarity NPD5211 Phase 2
0.736 Intermediate Similarity NPD8515 Approved
0.736 Intermediate Similarity NPD6908 Approved
0.736 Intermediate Similarity NPD8033 Approved
0.736 Intermediate Similarity NPD8513 Phase 3
0.736 Intermediate Similarity NPD8517 Approved
0.736 Intermediate Similarity NPD8516 Approved
0.736 Intermediate Similarity NPD6909 Approved
0.7355 Intermediate Similarity NPD8133 Approved
0.735 Intermediate Similarity NPD4767 Approved
0.735 Intermediate Similarity NPD4768 Approved
0.7339 Intermediate Similarity NPD5328 Approved
0.7328 Intermediate Similarity NPD5174 Approved
0.7328 Intermediate Similarity NPD5175 Approved
0.7321 Intermediate Similarity NPD5695 Phase 3
0.7317 Intermediate Similarity NPD6317 Approved
0.7315 Intermediate Similarity NPD3573 Approved
0.7304 Intermediate Similarity NPD5223 Approved
0.7297 Intermediate Similarity NPD6399 Phase 3
0.7281 Intermediate Similarity NPD7638 Approved
0.7281 Intermediate Similarity NPD5696 Approved
0.728 Intermediate Similarity NPD8377 Approved
0.728 Intermediate Similarity NPD8294 Approved
0.7265 Intermediate Similarity NPD5141 Approved
0.7258 Intermediate Similarity NPD6313 Approved
0.7258 Intermediate Similarity NPD6314 Approved
0.7257 Intermediate Similarity NPD5222 Approved
0.7257 Intermediate Similarity NPD4697 Phase 3
0.7257 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD5221 Approved
0.7248 Intermediate Similarity NPD6672 Approved
0.7248 Intermediate Similarity NPD5737 Approved
0.7236 Intermediate Similarity NPD6868 Approved
0.7232 Intermediate Similarity NPD7900 Approved
0.7232 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7227 Intermediate Similarity NPD4730 Approved
0.7227 Intermediate Similarity NPD4729 Approved
0.7222 Intermediate Similarity NPD8379 Approved
0.7222 Intermediate Similarity NPD8378 Approved
0.7222 Intermediate Similarity NPD8296 Approved
0.7222 Intermediate Similarity NPD6921 Approved
0.7222 Intermediate Similarity NPD8380 Approved
0.7222 Intermediate Similarity NPD8335 Approved
0.7222 Intermediate Similarity NPD7503 Approved
0.7217 Intermediate Similarity NPD7639 Approved
0.7217 Intermediate Similarity NPD7640 Approved
0.7207 Intermediate Similarity NPD6079 Approved
0.7193 Intermediate Similarity NPD5173 Approved
0.719 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD4754 Approved
0.7143 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD4225 Approved
0.7109 Intermediate Similarity NPD6067 Discontinued
0.7107 Intermediate Similarity NPD5247 Approved
0.7107 Intermediate Similarity NPD5251 Approved
0.7107 Intermediate Similarity NPD5248 Approved
0.7107 Intermediate Similarity NPD5249 Phase 3
0.7107 Intermediate Similarity NPD5250 Approved
0.7087 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5128 Approved
0.7064 Intermediate Similarity NPD3618 Phase 1
0.7054 Intermediate Similarity NPD6411 Approved
0.7027 Intermediate Similarity NPD6673 Approved
0.7027 Intermediate Similarity NPD4753 Phase 2
0.7027 Intermediate Similarity NPD6080 Approved
0.7027 Intermediate Similarity NPD6904 Approved
0.6991 Remote Similarity NPD4202 Approved
0.6964 Remote Similarity NPD6698 Approved
0.6964 Remote Similarity NPD46 Approved
0.6947 Remote Similarity NPD8074 Phase 3
0.6937 Remote Similarity NPD7513 Clinical (unspecified phase)
0.693 Remote Similarity NPD5282 Discontinued
0.6917 Remote Similarity NPD5956 Approved
0.6911 Remote Similarity NPD5215 Approved
0.6911 Remote Similarity NPD5216 Approved
0.6911 Remote Similarity NPD5217 Approved
0.6909 Remote Similarity NPD6684 Approved
0.6909 Remote Similarity NPD7146 Approved
0.6909 Remote Similarity NPD7334 Approved
0.6909 Remote Similarity NPD6409 Approved
0.6909 Remote Similarity NPD7521 Approved
0.6909 Remote Similarity NPD5330 Approved
0.6881 Remote Similarity NPD4786 Approved
0.6875 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6101 Approved
0.687 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6866 Remote Similarity NPD7260 Phase 2
0.6855 Remote Similarity NPD6053 Discontinued
0.6852 Remote Similarity NPD3667 Approved
0.6833 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6829 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6829 Remote Similarity NPD5169 Approved
0.6829 Remote Similarity NPD5135 Approved
0.6786 Remote Similarity NPD6903 Approved
0.6774 Remote Similarity NPD5127 Approved
0.6757 Remote Similarity NPD6098 Approved
0.6754 Remote Similarity NPD8035 Phase 2
0.6754 Remote Similarity NPD6050 Approved
0.6754 Remote Similarity NPD8034 Phase 2
0.6754 Remote Similarity NPD5693 Phase 1
0.6727 Remote Similarity NPD3665 Phase 1
0.6727 Remote Similarity NPD3666 Approved
0.6727 Remote Similarity NPD3133 Approved
0.6724 Remote Similarity NPD5210 Approved
0.6724 Remote Similarity NPD4629 Approved
0.6723 Remote Similarity NPD5344 Discontinued
0.6721 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6696 Remote Similarity NPD5779 Approved
0.6696 Remote Similarity NPD5778 Approved
0.6691 Remote Similarity NPD6845 Suspended
0.6667 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4695 Discontinued
0.6667 Remote Similarity NPD7632 Discontinued
0.6667 Remote Similarity NPD5329 Approved
0.6667 Remote Similarity NPD5692 Phase 3
0.6667 Remote Similarity NPD5168 Approved
0.6641 Remote Similarity NPD8080 Discontinued
0.6614 Remote Similarity NPD5167 Approved
0.6609 Remote Similarity NPD5694 Approved
0.6609 Remote Similarity NPD7983 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data